LBA53 IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma: Primary phase III results (IOB-013/KN-D18)
Articles > Article ยท 2025
Authors: J.C. Hassel, A.M. Arance, M.S. Carlino, P.A. Ascierto, S.K. Sandhu, I. Puzanov, A.M.M. Eggermont, O. Hamid, L. Mortier, P. Rutkowski, C. Coetzee, S.B. Karaca Yayla, S. Grabbe, A. Poklepovic, A.V. Christiansen, B. Wang, Q.I. Ahmad, F. Ringeisen, C. Robert, I.M. Svane
Annals of Oncology, International, WoS, 2025, vol 36, pp S1597-S1598